Skip to main content
. 2022 Jul 27;50(10):e744–e758. doi: 10.1097/CCM.0000000000005627

TABLE 1.

Group Statistics for Outcomes of Patients on Renin-Angiotensin-Aldosterone System Inhibitors Only, Renin-Angiotensin-Aldosterone System Inhibitors and Other Antihypertensive Agents and Other Antihypertensive Agents Only

Outcomes RAASIs Only (N = 1,542) RAASIs and Other AHAs (N = 2,668) Other AHAs Only (N = 3,765) p
Analysis of Variance RAASIs Only vs Both Medications Both Medications vs Other AHAs Only RAASIs vs Other AHAs Only
In-hospital mortality, n (%) 286 (18.5) 640 (24.0) 884 (23.5) < 0.0001 < 0.0001 0.66 < 0.0001
Use of CRRT/hemodialysis, n (%) 66 (4.2) 207 (7.5) 230 (5.9) < 0.0001 < 0.0001 0.013 0.012
Time on CRRT (d), mean ± sd 10.0 ± 9.3 9.4 ± 10.1 10.7 ± 11.5 0.42 0.63 0.20 0.60
Use of extracorporeal membrane oxygenation, n (%) 19 (1.2) 24 (0.9) 27 (0.7) 0.19 0.38 0.50 0.094
Admitted to ICU, n (%) 713 (46.4) 1,241 (47.1) 1,669 (46.9) 0.92 0.71 0.93 0.77
ICU length of stay (d),  mean ± sd 14.3 ± 15.3 12.7 ± 12.8 12.0 ± 12.7 < 0.0001 < 0.0001 0.0003 < 0.0001
Hospital length of stay (d),  mean ± sd 15.9 ± 19.7 15.1 ± 14.3 15.0 ± 16.7 0.0011 0.0027 0.56 0.0007
Use of mechanical ventilation,  n (%) 424 (27.5) 786 (29.5) 1,004 (26.7) 0.046 0.19 0.015 0.56
Time on ventilator (d), mean ± sd 14.9 ± 14.8 13.1 ± 12.1 13.2 ± 14.9 0.072 0.024 0.87 0.052
Complications during hospitalization, n (%)
 Respiratory failure (acute respiratory distress syndrome) 320 (20.8) 576 (21.6) 729 (19.4) 0.085 0.55 0.031 0.26
  Mild (P:F 200–300) 21 (8.1) 60 (12.5) 62 (10.5) 0.31 0.10 0.60 0.32
  Moderate (P:F 100–199) 73 (28.1) 146 (30.4) 181 (30.7)
  Severe (P:F < 100) 166 (63.8) 275 (57.2) 347 (58.8)
 Septic shock 170 (11.0) 355 (13.3) 435 (11.6) 0.041 0.035 0.038 0.61
 Congestive heart failure 24 (1.6) 93 (3.5) 116 (3.1) 0.0012 0.0004 0.41 0.0023
 Cardiac arrhythmia 78 (5.1) 202 (7.6) 232 (6.2) 0.0040 0.0020 0.030 0.14
 Stroke 15 (1.0) 47 (1.8) 39 (1.0) 0.019 0.056 0.017 0.95
 Co- or secondary infection 66 (4.3) 139 (5.2) 156 (4.1) 0.11 0.20 0.051 0.88

AHAs = antihypertensive agents, CRRT = continuous renal replacement therapy, P:F = Pao2:Fio2 ratio, RAASIs = renin-angiotensin-aldosterone system inhibitors.

Boldface values indicate statistical significance.